The idea behind the delay, Johnson said Monday, is to get more people vaccinated, especially with their second dose, before all restrictions are lifted. Recent studies indicate that after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech coronavirus vaccine, people are only about 33 percent protected from the delta variant, but that increases to more than 80 percent with the second dose.